CNBC's Meg Tirrell and David Ricks, Eli Lilly CEO, joins 'Closing Bell: Overtime' to discuss the company's decision to slash insulin prices. He also discusses his economic outlook and the timeline for

Eli Lilly to slash prices for insulin drugs by 70%

04:20pm, Wednesday, 01'st Mar 2023
The changes could help around 2 million people pay for the life-sustaining drug.
Eli Lilly's announcement that it will cut the price of insulin for people with commercial health insurance — capping out-of-pocket insulin costs to $35 — highlights just how much money people are

Eli Lilly cuts insulin prices by 70%

02:16pm, Wednesday, 01'st Mar 2023
CNBC's Meg Tirrell joins 'The Exchange' to discuss Eli Lilly's decision to set insulin price caps, the motivations behind the company's decision, and whether or not other insulin producers will join t
Eli Lilly announced a 70% price cut for most of its insulins Wednesday in a move its CEO described as "aggressive." Eli Lilly stock jumped.
The drugmaker says it's also cutting prices by 70% for its most commonly prescribed insulins.

Eli Lilly to cut insulin prices by 70%

11:43am, Wednesday, 01'st Mar 2023
Eli Lilly and Co (NYSE:LLY) announced it is reducing the price of most of its commonly prescribed insulins by 70% and the expansion of its Insulin Value Program that caps patient out-of-pocket costs a
Here's a positive news item for U.S. insulin users. Drugmaker Eli Lilly (NYSE: LLY ) just revealed that it's reducing the cost of its most commonly prescribed insulin products by 70%.

Lilly cuts insulin prices by 70%

09:32am, Wednesday, 01'st Mar 2023
CNBC's Meg Tirrell reports on news from Eli Lilly.
Eli Lilly said it will cut the price of its insulins by 70% and cap out-of-pocket prices. But Eli Lilly stock was muted Wednesday.
Eli Lilly & Co. LLY said Wednesday that is capping out-of-pocket insulin costs to $35 for people with commercial health insurance at certain retail pharmacies and it is also lowering the prices of mos
Drugmaker Eli Lilly & Co. on Wednesday said it will cut prices of its most commonly prescribed insulins by 70% and cap monthly prices at $35 per month at certain retail pharmacies for people who have
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Eli Lilly and Company (NYSE: LLY) is one of the most recognized names in the pharmaceutical industry. Indeed, they are the 12th-largest pharmaceutical company in the world by revenue ($5.5 billion in
These three defensive stocks could cushion your portfolio from market volatility this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE